NIH-funded research R01 grant

Understanding how gut and body signals interact to influence perinatal depression

Official title: Prediction, mechanisms and causality: a systems biology approach to elucidate the role of the dynamic interplay between maternal and microbial systems in the pathobiology of perinatal depression

Funded at University of Illinois at Chicago · NIH-11372334 · Data updated 2026-11-12

A study of pregnant people exploring how the gut microbiome and body signals contribute to depression during and after pregnancy.

More Depression research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startSeptember 16, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$653,633
NIH project number5R01HD113809-03
Project IDNIH-11372334 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people, especially those in the first or second trimester and from diverse backgrounds, who may be at risk for perinatal depression.

Less likely to help

People without participation in the study or those without depressive symptoms may have limited direct benefit.

What this research studies

This project follows pregnant people to understand how changes in gut bacteria and their chemical messages relate to mood changes across pregnancy and after birth. Researchers will look at gut-derived molecules, neurotransmitters like serotonin and GABA, and how inflammation and metabolic signals connect the gut to the brain. The study uses longitudinal data from a diverse group of participants to identify MGBA signatures that accompany depressive symptoms in the first and second trimesters and beyond. Results could point to new ways to predict and prevent perinatal depression by targeting gut-brain communication.

Why it matters

Potential benefit: If successful, this work could lead to earlier prediction and better prevention or treatment approaches for perinatal depression.

How similar studies have gone: Preliminary data suggest MGBA signatures correlate with depressive symptoms, indicating potential for meaningful findings with larger cohorts.

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Penalver Bernabe, Beatriz — University of Illinois at Chicago
  • Study coordinator: Penalver Bernabe, Beatriz

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.